{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:16:09Z","timestamp":1788416169846,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ7\/02756"],"award-info":[{"award-number":["2019\/35\/B\/NZ7\/02756"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The epidemiology data for candidiasis indicate an increase in\n                    <jats:italic>Candida glabrata<\/jats:italic>\n                    infections. Moreover, several reports have shown an increasing number of drug-resistant cases of these infections. The source of drug resistance can often be traced to genetic mutations in genes related to a drug\u2019s mechanism of action. Therefore, we conducted whole genome sequencing of several drug-resistant isolates of\n                    <jats:italic>Candida glabrata<\/jats:italic>\n                    collected from patients hospitalized in Eastern Poland to assess whether mutations in selected genes correlated with susceptibility analysis results. The fungal species from patient samples were identified, and the isolated\n                    <jats:italic>Candida glabrata<\/jats:italic>\n                    were subjected to antifungal drug susceptibility testing. The results were interpreted according to the EUCAST and CLSI recommendations. Susceptibility to 5-flucytosine was assessed using the ATB FUNGUS kit. Libraries were prepared according to the NEXTERA XT DNA Library Prep and subsequently sequenced. The outcomes indicated common resistance to two of the three analyzed echinocandins, as well as two cases of simultaneous resistance to echinocandins and selected azole-based drugs. We detected several previously reported mutations in selected resistance-related genes, as well as five that are first described here:\n                    <jats:italic>ERG5<\/jats:italic>\n                    (M267I),\n                    <jats:italic>ERG6<\/jats:italic>\n                    (R57K),\n                    <jats:italic>PDH1<\/jats:italic>\n                    (K438Q, V434I, F600V, V1192S),\n                    <jats:italic>FCY1<\/jats:italic>\n                    (M129T), and\n                    <jats:italic>FCY2<\/jats:italic>\n                    (I384F). Neither of the identified nonsynonymous mutations was correlated with the drug resistance demonstrated in the susceptibility testing. Furthermore, we can exclude the possibility of acquired drug resistance, thereby raising questions about the possibility of unknown mechanisms of resistance to azole-based and echinocandin drugs.\n                  <\/jats:p>","DOI":"10.1007\/s12223-025-01298-w","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T08:33:50Z","timestamp":1752482030000},"page":"889-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Whole genome sequencing analysis of Candida glabrata isolates collected from patients with selected drug-resistant candidiasis hospitalized in Eastern Poland"],"prefix":"10.1007","volume":"71","author":[{"given":"Sebastian","family":"Kubica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Szuli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Kruszniewska-Rajs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kimsa-Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Olender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Bogut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Szuka\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Gago\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3089-0409","authenticated-orcid":false,"given":"Joanna Magdalena","family":"Gola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"1298_CR1","doi-asserted-by":"publisher","first-page":"e01900","DOI":"10.1128\/AAC.01900-18","volume":"63","author":"S Ahmad","year":"2019","unstructured":"Ahmad S, Joseph L, Parker JE et al (2019) ERG6 and ERG2 are major targets conferring reduced susceptibility to amphotericin B in clinical Candida glabrata isolates in Kuwait. Antimicrob Agents Chemother 63:e01900\u2013e01918. https:\/\/doi.org\/10.1128\/AAC.01900-18","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab122","volume":"3","author":"AM Aldejohann","year":"2021","unstructured":"Aldejohann AM, Herz M, Martin R et al (2021) Emergence of resistant Candida glabrata in Germany. JAC Antimicrob Resist 3:dlab122. https:\/\/doi.org\/10.1093\/jacamr\/dlab122","journal-title":"JAC Antimicrob Resist"},{"key":"1298_CR3","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul SF, Madden TL, Sch\u00e4ffer AA et al (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389\u20133402. https:\/\/doi.org\/10.1093\/nar\/25.17.3389","journal-title":"Nucleic Acids Res"},{"key":"1298_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","volume":"87","author":"MC Arendrup","year":"2023","unstructured":"Arendrup MC, Arikan-Akdagli S, J\u00f8rgensen KM et al (2023) European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study. J Infect 87:428\u2013437. https:\/\/doi.org\/10.1016\/j.jinf.2023.08.001","journal-title":"J Infect"},{"key":"1298_CR5","unstructured":"Babraham Bioinformatics (2023) FastQC a quality control tool for high throughput sequence data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/. Accessed 31 Jul 2024"},{"key":"1298_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/cid\/ciu407","volume":"59","author":"ND Beyda","year":"2014","unstructured":"Beyda ND, John J, Kilic A et al (2014) FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis 59:819\u2013825. https:\/\/doi.org\/10.1093\/cid\/ciu407","journal-title":"Clin Infect Dis"},{"key":"1298_CR7","doi-asserted-by":"publisher","DOI":"10.3791\/56714","volume":"56714","author":"C Biswas","year":"2017","unstructured":"Biswas C, Chen SC-A, Halliday C et al (2017) Whole genome sequencing of Candida glabrata for detection of markers of antifungal drug resistance. J Vis Exp 56714:56714. https:\/\/doi.org\/10.3791\/56714","journal-title":"J Vis Exp"},{"key":"1298_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02946","volume":"9","author":"C Biswas","year":"2018","unstructured":"Biswas C, Marcelino VR, Van Hal S et al (2018) Whole genome sequencing of Australian Candida glabrata isolates reveals genetic diversity and novel sequence types. Front Microbiol 9:2946. https:\/\/doi.org\/10.3389\/fmicb.2018.02946","journal-title":"Front Microbiol"},{"key":"1298_CR9","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"1298_CR10","doi-asserted-by":"publisher","first-page":"e0092022","DOI":"10.1128\/mbio.00920-22","volume":"13","author":"S Bretagne","year":"2022","unstructured":"Bretagne S, Sitbon K, Desnos-Ollivier M et al (2022) Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF network (2012 to 2018). MBio 13:e0092022. https:\/\/doi.org\/10.1128\/mbio.00920-22","journal-title":"MBio"},{"key":"1298_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/AAC.01674-13","volume":"58","author":"M Castanheira","year":"2014","unstructured":"Castanheira M, Woosley LN, Messer SA et al (2014) Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates. Antimicrob Agents Chemother 58:577\u2013580. https:\/\/doi.org\/10.1128\/AAC.01674-13","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/jac\/dkab454","volume":"77","author":"A Ceballos-Garzon","year":"2022","unstructured":"Ceballos-Garzon A, Monteoliva L, Gil C et al (2022) Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata. J Antimicrob Chemother 77:585\u2013597. https:\/\/doi.org\/10.1093\/jac\/dkab454","journal-title":"J Antimicrob Chemother"},{"key":"1298_CR13","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1128\/AAC.01568-07","volume":"52","author":"JD Cleary","year":"2008","unstructured":"Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS (2008) Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Chemother 52:2263\u20132265. https:\/\/doi.org\/10.1128\/AAC.01568-07","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR14","unstructured":"CLSI (2022) M27 M44S Ed3 | Performance standards for antifungal susceptibility testing of yeasts, 3rd edition. In: Clinical and Laboratory Standards Institute. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27m44s\/. Accessed 5 Sep 2024."},{"key":"1298_CR15","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","volume":"17","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, de Almeida J\u00fanior JN, Slavin MA et al (2017) Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis 17:e344\u2013e356. https:\/\/doi.org\/10.1016\/S1473-3099(17)30304-3","journal-title":"Lancet Infect Dis"},{"key":"1298_CR16","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1128\/AAC.00605-10","volume":"54","author":"TD Edlind","year":"2010","unstructured":"Edlind TD, Katiyar SK (2010) Mutational analysis of flucytosine resistance in Candida glabrata. Antimicrob Agents Chemother 54:4733\u20134738. https:\/\/doi.org\/10.1128\/AAC.00605-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR17","unstructured":"EUCAST (2023) European committee on antimicrobial susceptibility testing. Overview of antifungal ECOFFs and clinical breakpoints for yeasts, moulds and dermatophytes using the EUCAST E.Def 7.4, E.Def 9.4 and E.Def 11.0 procedures, Version 4.0. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Clinical_breakpoints\/EUCAST_BP_ECOFF_v_4.0.pdf. Accessed 10 July 2025"},{"key":"1298_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000268","volume":"5","author":"S Ferrari","year":"2009","unstructured":"Ferrari S, Ischer F, Calabrese D et al (2009) Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 5:e1000268. https:\/\/doi.org\/10.1371\/journal.ppat.1000268","journal-title":"PLoS Pathog"},{"key":"1298_CR19","doi-asserted-by":"publisher","unstructured":"Garrison E, Marth G (2012) Haplotype-based variant detection from short-read sequencing. https:\/\/doi.org\/10.48550\/arxiv.1207.3907","DOI":"10.48550\/arxiv.1207.3907"},{"key":"1298_CR20","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E, Gattiker A, Hoogland C et al (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31:3784\u20133788. https:\/\/doi.org\/10.1093\/nar\/gkg563","journal-title":"Nucleic Acids Res"},{"key":"1298_CR21","doi-asserted-by":"publisher","unstructured":"Gopinathan S, Janagond AB, Agatha D, Thenmozhivalli PR (2013) Detection of FUR1 Gene in 5-flucytosine resistant Candida Isolates in vaginal candidiasis patients. J Clin Diagn Res 7:2452\u20132455. https:\/\/doi.org\/10.7860\/JCDR\/2013\/6160.3574","DOI":"10.7860\/JCDR\/2013\/6160.3574"},{"key":"1298_CR22","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.1117280109","volume":"109","author":"KC Gray","year":"2012","unstructured":"Gray KC, Palacios DS, Dailey I et al (2012) Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A 109:2234\u20132239. https:\/\/doi.org\/10.1073\/pnas.1117280109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1298_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/ajcp\/36.3.227","volume":"36","author":"LD Haley","year":"1961","unstructured":"Haley LD (1961) Yeasts of medical importance. Am J Clin Pathol 36:227\u2013234. https:\/\/doi.org\/10.1093\/ajcp\/36.3.227","journal-title":"Am J Clin Pathol"},{"key":"1298_CR24","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1128\/AAC.01145-12","volume":"56","author":"CM Hull","year":"2012","unstructured":"Hull CM, Bader O, Parker JE et al (2012) Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2. Antimicrob Agents Chemother 56:6417\u20136421. https:\/\/doi.org\/10.1128\/AAC.01145-12","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"key":"1298_CR26","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A et al (2009) The Sequence Alignment\/Map format and SAMTOOLS. Bioinformatics 25:2078\u20132079. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352","journal-title":"Bioinformatics"},{"key":"1298_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jof9050515","volume":"9","author":"HJ Lim","year":"2023","unstructured":"Lim HJ, Choi MJ, Byun SA et al (2023) Whole-genome sequence analysis of Candida glabrata isolates from a patient with persistent fungemia and determination of the molecular mechanisms of multidrug resistance. J Fungi (Basel) 9:515. https:\/\/doi.org\/10.3390\/jof9050515","journal-title":"J Fungi (Basel)"},{"key":"1298_CR28","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/AAC.00348-10","volume":"54","author":"CM Martel","year":"2010","unstructured":"Martel CM, Parker JE, Bader O et al (2010) Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob Agents Chemother 54:4527\u20134533. https:\/\/doi.org\/10.1128\/AAC.00348-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR29","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1128\/AAC.00303-10","volume":"54","author":"CM Martel","year":"2010","unstructured":"Martel CM, Parker JE, Bader O et al (2010) A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrob Agents Chemother 54:3578\u20133583. https:\/\/doi.org\/10.1128\/AAC.00303-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR30","doi-asserted-by":"publisher","first-page":"e01140","DOI":"10.1128\/jcm.01140-23","volume":"62","author":"E Misas","year":"2024","unstructured":"Misas E, Seagle E, Jenkins EN et al (2024) Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates. J Clin Microbiol 62:e01140\u2013e01223. https:\/\/doi.org\/10.1128\/jcm.01140-23","journal-title":"J Clin Microbiol"},{"key":"1298_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/mmy\/myz014","volume":"58","author":"P Navarro-Rodr\u00edguez","year":"2020","unstructured":"Navarro-Rodr\u00edguez P, Martin-Vicente A, L\u00f3pez-Fern\u00e1ndez L et al (2020) Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains. Med Mycol 58:30\u201338. https:\/\/doi.org\/10.1093\/mmy\/myz014","journal-title":"Med Mycol"},{"key":"1298_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/00365549109024310","volume":"23","author":"H Nielsen","year":"1991","unstructured":"Nielsen H, Stenderup J, Bruun B (1991) Fungemia in a university hospital 1984\u20131988. Clinical and mycological characteristics. Scand J Infect Dis 23:275\u2013282. https:\/\/doi.org\/10.3109\/00365549109024310","journal-title":"Scand J Infect Dis"},{"key":"1298_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1590\/0074-0276140099","volume":"109","author":"P Paluchowska","year":"2014","unstructured":"Paluchowska P, Tokarczyk M, Bogusz B et al (2014) Molecular epidemiology of Candida albicans and Candida glabrata strains isolated from intensive care unit patients in Poland. Mem Inst Oswaldo Cruz 109:436\u2013441. https:\/\/doi.org\/10.1590\/0074-0276140099","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1298_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/yea.1387","volume":"23","author":"JP Paluszynski","year":"2006","unstructured":"Paluszynski JP, Klassen R, Rohe M, Meinhardt F (2006) Various cytosine\/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. Yeast 23:707\u2013715. https:\/\/doi.org\/10.1002\/yea.1387","journal-title":"Yeast"},{"key":"1298_CR35","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","volume":"49","author":"S Park","year":"2005","unstructured":"Park S, Kelly R, Kahn JN et al (2005) Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49:3264\u20133273. https:\/\/doi.org\/10.1128\/AAC.49.8.3264-3273.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","volume":"10","author":"DS Perlin","year":"2007","unstructured":"Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10:121\u2013130. https:\/\/doi.org\/10.1016\/j.drup.2007.04.002","journal-title":"Drug Resist Updat"},{"key":"1298_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000221854","volume":"21","author":"A Polak","year":"1975","unstructured":"Polak A, Scholer HJ (1975) Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 21:113\u2013130. https:\/\/doi.org\/10.1159\/000221854","journal-title":"Chemotherapy"},{"key":"1298_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jof7060491","volume":"7","author":"M Risum","year":"2021","unstructured":"Risum M, Astvad K, Johansen HK et al (2021) Update 2016\u20132018 of the nationwide Danish fungaemia surveillance study: epidemiologic changes in a 15-year perspective. J Fungi (Basel) 7:491. https:\/\/doi.org\/10.3390\/jof7060491","journal-title":"J Fungi (Basel)"},{"key":"1298_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1699-0463.1962.tb05088.x","volume":"54","author":"A Stenderup","year":"1962","unstructured":"Stenderup A, Pedersen GT (1962) Yeasts of human origin. Acta Pathol Microbiol Scand 54:462\u2013472. https:\/\/doi.org\/10.1111\/j.1699-0463.1962.tb05088.x","journal-title":"Acta Pathol Microbiol Scand"},{"key":"1298_CR40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1099\/jmm.0.000062","volume":"64","author":"P Szweda","year":"2015","unstructured":"Szweda P, Gucwa K, Romanowska E et al (2015) Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland. J Med Microbiol 64:610\u2013619. https:\/\/doi.org\/10.1099\/jmm.0.000062","journal-title":"J Med Microbiol"},{"key":"1298_CR41","doi-asserted-by":"publisher","unstructured":"Szyma\u0144ski M, Chmielewska S, Czy\u017cewska U et al (2022) Echinocandins \u2013 structure, mechanism of action and use in antifungal therapy. J Enzyme Inhib Med Chem 37:876\u2013894. https:\/\/doi.org\/10.1080\/14756366.2022.2050224","DOI":"10.1080\/14756366.2022.2050224"},{"key":"1298_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.794235","volume":"11","author":"M Szymankiewicz","year":"2021","unstructured":"Szymankiewicz M, Kamecki K, Jarzynka S et al (2021) Case report: echinocandin-resistance Candida glabrata FKS mutants from patient following radical cystoprostatectomy due to muscle-invasive bladder cancer. Front Oncol 11:794235. https:\/\/doi.org\/10.3389\/fonc.2021.794235","journal-title":"Front Oncol"},{"key":"1298_CR43","doi-asserted-by":"publisher","unstructured":"Timmermans B, De Las Pe\u00f1as A, Casta\u00f1o I, Van Dijck P (2018) Adhesins in Candida glabrata. J Fungi (Basel) 4(2):60. https:\/\/doi.org\/10.3390\/jof4020060","DOI":"10.3390\/jof4020060"},{"key":"1298_CR44","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1128\/AAC.00535-10","volume":"54","author":"H-F Tsai","year":"2010","unstructured":"Tsai H-F, Sammons LR, Zhang X et al (2010) Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob Agents Chemother 54:3308\u20133317. https:\/\/doi.org\/10.1128\/AAC.00535-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR45","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1128\/AAC.00423-08","volume":"52","author":"P Vandeputte","year":"2008","unstructured":"Vandeputte P, Tronchin G, Larcher G et al (2008) A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata. Antimicrob Agents Chemother 52:3701\u20133709. https:\/\/doi.org\/10.1128\/AAC.00423-08","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11046-010-9342-1","volume":"171","author":"P Vandeputte","year":"2011","unstructured":"Vandeputte P, Pineau L, Larcher G et al (2011) Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata. Mycopathologia 171:11\u201321. https:\/\/doi.org\/10.1007\/s11046-010-9342-1","journal-title":"Mycopathologia"},{"key":"1298_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","volume":"46","author":"A Vermes","year":"2000","unstructured":"Vermes A, Guchelaar HJ, Dankert J (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46:171\u2013179. https:\/\/doi.org\/10.1093\/jac\/46.2.171","journal-title":"J Antimicrob Chemother"},{"key":"1298_CR48","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","volume":"20","author":"RP Wenzel","year":"1995","unstructured":"Wenzel RP (1995) Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20:1531\u20131534. https:\/\/doi.org\/10.1093\/clinids\/20.6.1531","journal-title":"Clin Infect Dis"},{"key":"1298_CR49","doi-asserted-by":"publisher","first-page":"e01070","DOI":"10.1128\/AAC.01070-18","volume":"62","author":"SG Whaley","year":"2018","unstructured":"Whaley SG, Zhang Q, Caudle KE, Rogers PD (2018) Relative contribution of the ABC transporters Cdr1, Pdh1, and Snq2 to azole resistance in Candida glabrata. Antimicrob Agents Chemother 62:e01070\u2013e01118. https:\/\/doi.org\/10.1128\/AAC.01070-18","journal-title":"Antimicrob Agents Chemother"},{"key":"1298_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrp.2010.12.009","volume":"1","author":"JI Yoo","year":"2010","unstructured":"Yoo JI, Choi CW, Lee KM, Lee YS (2010) Gene expression and identification related to fluconazole resistance of Candida glabrata Strains. Osong Public Health Res Perspect 1:36\u201341. https:\/\/doi.org\/10.1016\/j.phrp.2010.12.009","journal-title":"Osong Public Health Res Perspect"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01298-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:46:15Z","timestamp":1788414375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01298-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01298-w","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Bioethics Committee at the Medical University of Lublin\u2014No. KE-0254\/294\/2020 of December 17, 2020.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}